{"transactions":[{"id":4623708,"issuer":{"id":9265,"kind":"organization","name":"Electra Therapeutics, Inc.","symbol":"ETRA"},"owners":[{"id":183844,"kind":"person","name":"Dong Quehuong (Kathy)","position":1,"cik":"0002153364","reported_name":"Dong Quehuong (Kathy)","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Series A Convertible Preferred Stock","published_at":"2026-09-21T22:14:36.000Z","date":"2026-09-21","kind":"exercise","planned":false,"acquired":false,"shares":455484,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of  Series A Convertible Preferred Stock (the \"Preferred Stock\") converted automatically into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F1","text":"73,147 of the shares (\"Restricted Shares\") shall be subject to vesting as follows: 1/13th of the Restricted Shares shall vest monthly commencing from September 16, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of  Series A Convertible Preferred Stock (the \"Preferred Stock\") converted automatically into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of  Series A Convertible Preferred Stock (the \"Preferred Stock\") converted automatically into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of  Series A Convertible Preferred Stock (the \"Preferred Stock\") converted automatically into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"73,147 of the shares (\"Restricted Shares\") shall be subject to vesting as follows: 1/13th of the Restricted Shares shall vest monthly commencing from September 16, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":455484},"source":{"system":"sec-edgar","filing":"0002153364-26-000004","document":"form4-09212026_100932.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2153364/000215336426000004/form4-09212026_100932.xml","form_type":"4"}},{"id":4623707,"issuer":{"id":9265,"kind":"organization","name":"Electra Therapeutics, Inc.","symbol":"ETRA"},"owners":[{"id":183844,"kind":"person","name":"Dong Quehuong (Kathy)","position":1,"cik":"0002153364","reported_name":"Dong Quehuong (Kathy)","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-09-21T22:14:36.000Z","date":"2026-09-21","kind":"exercise","planned":false,"acquired":true,"shares":455484,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"73,147 of the shares (\"Restricted Shares\") shall be subject to vesting as follows: 1/13th of the Restricted Shares shall vest monthly commencing from September 16, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of  Series A Convertible Preferred Stock (the \"Preferred Stock\") converted automatically into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date."}],"balance_after":455484,"source":{"system":"sec-edgar","filing":"0002153364-26-000004","document":"form4-09212026_100932.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2153364/000215336426000004/form4-09212026_100932.xml","form_type":"4"}}]}